RADIONUCLIDE BRACHYTHERAPY SOURCE— 510(k) K093663

Substantially Equivalent

C.R. Bard, Inc.

FDA 510(k) clearance K093663 for RADIONUCLIDE BRACHYTHERAPY SOURCE, Substantially Equivalent on 2009-12-23. Applicant: C.R. Bard, Inc..

Clearance details

Applicant: C.R. Bard, Inc.
Product code: Code KXK
Advisory panel: Radiology
Date received: 2009-11-25
Decision date: 2009-12-23
Decision: Substantially Equivalent
Clearance type: Special
Location: Covington, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.